David E. Lazar Titan Pharmaceuticals Inc (TTNP) insider trading activity

David E. Lazar is Chief Executive Officer of TITAN PHARMACEUTICALS INC. Currently has a direct ownership of 100,000 shares of TTNP, which is worth approximately $352,000. The most recent transaction as insider was on Jul 26, 2023, when has been sold 100,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K

0% 3M change

0% 12M change

Total Value Held $352,000

David E. Lazar Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 26 2023	BUY Grant, award, or other acquisition	-	100,000 Added 50.0%	100,000 Common Stock
Jun 21 2023	SELL Open market or private sale	$4,168,349 $1.23 p/Share	3,388,902 Reduced 100.0%	0 Common Stock, par valu...
Jan 25 2023	BUY Open market or private purchase	$20,000 $1.0 p/Share	20,000 Added 0.59%	3,388,902 Common Stock, par valu...
Jan 24 2023	BUY Open market or private purchase	$36,375 $0.97 p/Share	37,500 Added 1.1%	3,368,902 Common Stock, par valu...
Jul 07 2022	BUY Open market or private purchase	$736,851 $0.99 p/Share	744,294 Added 18.26%	3,331,402 Common Stock, par valu...
Jul 06 2022	BUY Open market or private purchase	$897,801 $0.77 p/Share	1,165,975 Added 31.07%	2,587,108 Common Stock, par valu...

Also insider at

MINM

MINIM, INC. Technology

Director

OPGN

OPGEN INC Healthcare

Chief Executive Officer

LQR

LQR House Inc.

President

DEL

David E. Lazar

Chief Executive Officer

Dubai, C0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TTNP shares.

Notify only if

Value

Insider Trading

Get notified when an Titan Pharmaceuticals Inc insider buys or sells TTNP shares.

Notify only if

Operation

Value

Type

News

Receive news related to TITAN PHARMACEUTICALS INC

Track Activities on TTNP

Account